Thomas Chang, MD - Medicare Psychiatry & Neurology in Las Vegas, NV

Thomas Chang, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Las Vegas, Nevada. His current practice location is 8950 W Tropicana Ave Ste 1, Las Vegas, Nevada. You can reach out to his office (for appointments etc.) via phone at (702) 790-2701.

Thomas Chang is licensed to practice in Nevada (license number 21611) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1043876931.

Contact Information

Thomas Chang, MD
8950 W Tropicana Ave Ste 1,
Las Vegas, NV 89147-8138
(702) 790-2701
Not Available



Physician's Profile

Full NameThomas Chang
GenderMale
SpecialityPsychiatry & Neurology - Psychiatry
Location8950 W Tropicana Ave Ste 1, Las Vegas, Nevada
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1043876931
  • Provider Enumeration Date: 05/15/2019
  • Last Update Date: 07/19/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3779819933
  • Enrollment ID: I20230711001066

Medical Identifiers

Medical identifiers for Thomas Chang such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043876931NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 21611 (Nevada)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Thomas Chang allows following entities to bill medicare on his behalf.
Entity NameFocus Mental Health Solutions Bhushan Manjooran Wirjo Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1336483742
PECOS PAC ID: 9537312863
Enrollment ID: O20130116000365

News Archive

CorMedix seeks QIDP designation from FDA for Neutrolin Catheter Lock Solution

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.

UCB presents data on Vimpat AED at AES meeting

UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.

Novelos completes I-131-CLR1404 Phase 1b trial on advanced solid tumors

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it has successfully completed the first cohort in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound I-131-CLR1404 (HOT) in cancer patients with advanced solid tumors.

Scientists engineer smallest CRISPR-Cas9 system to date

Scientists at the Center for Genome Engineering, within the Institute for Basic Science0, in collaboration with KIM Eunji and KIM Jeong Hun have engineered the smallest CRISPR-Cas9 to date, delivered it to the muscle cells and in the eyes of mice via adeno-associated viruses and used it to modify a gene causing blindness.

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas Chang is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Thomas Chang, MD
10170 W Tropicana Ave # 156-411,
Las Vegas, NV 89147-8465

Ph: () -
Thomas Chang, MD
8950 W Tropicana Ave Ste 1,
Las Vegas, NV 89147-8138

Ph: (702) 790-2701

News Archive

CorMedix seeks QIDP designation from FDA for Neutrolin Catheter Lock Solution

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.

UCB presents data on Vimpat AED at AES meeting

UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.

Novelos completes I-131-CLR1404 Phase 1b trial on advanced solid tumors

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it has successfully completed the first cohort in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound I-131-CLR1404 (HOT) in cancer patients with advanced solid tumors.

Scientists engineer smallest CRISPR-Cas9 system to date

Scientists at the Center for Genome Engineering, within the Institute for Basic Science0, in collaboration with KIM Eunji and KIM Jeong Hun have engineered the smallest CRISPR-Cas9 to date, delivered it to the muscle cells and in the eyes of mice via adeno-associated viruses and used it to modify a gene causing blindness.

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

Read more News

› Verified 4 days ago


Psychiatry & Neurology Doctors in Las Vegas, NV

Dr. Ejine Okoroafor, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146
Phone: 914-426-7774    
Dr. Garet Jefferson Zaugg, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2020 Wellness Way Ste 300, Las Vegas, NV 89106
Phone: 702-432-2233    Fax: 702-800-5456
Dr. Muhammed A Hyder, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2465 E Twain Ave, Las Vegas, NV 89121
Phone: 702-789-6201    Fax: 304-522-0686
Dr. Krista Linn Pinard, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102
Phone: 702-790-2701    
Gobinder S. Chopra, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148
Phone: 702-796-8500    Fax: 702-796-8502
Eden Santiago Lee, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102
Phone: 702-671-6475    Fax: 702-671-6440
John Reitano, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106
Phone: 702-897-7250    Fax: 702-706-4838

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.